AAAAAA

   
Results: 1-25 | 26-42 |
Results: 26-42/42

Authors: DAVIES PH BLACK EG SHEPPARD MC FRANKLYN JA
Citation: Ph. Davies et al., RELATION BETWEEN SERUM INTERLEUKIN-6 AND THYROID-HORMONE CONCENTRATIONS IN 270 HOSPITAL INPATIENTS WITH NONTHYROIDAL ILLNESS, Clinical endocrinology, 44(2), 1996, pp. 199-205

Authors: CHAMBA A NEUBERGER J STRAIN A HOPKINS J SHEPPARD MC FRANKLYN JA
Citation: A. Chamba et al., EXPRESSION AND FUNCTION OF THYROID-HORMONE RECEPTOR VARIANTS IN NORMAL AND CHRONICALLY DISEASED HUMAN LIVER, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 360-367

Authors: FRANKLYN JA DAYKIN J HOLDER R SHEPPARD MC
Citation: Ja. Franklyn et al., RADIOIODINE THERAPY COMPARED IN PATIENTS WITH TOXIC NODULAR OR GRAVESHYPERTHYROIDISM, Quarterly Journal of Medicine, 88(3), 1995, pp. 175-180

Authors: FRANKLYN JA BETTERIDGE J HOLDER R SHEPPARD MC
Citation: Ja. Franklyn et al., EFFECT OF ESTROGEN REPLACEMENT THERAPY UPON BONE-MINERAL DENSITY IN THYROXINE-TREATED POSTMENOPAUSAL WOMEN WITH A PAST HISTORY OF THYROTOXICOSIS, Thyroid, 5(5), 1995, pp. 359-363

Authors: BURRA P FITCH NJS KAPADI A FRANKLYN JA SHEPPARD MC RAMSDEN DB ELIAS E
Citation: P. Burra et al., THE EFFECTS OF ETHANOL, 3,5,3'-TRIIODOTHYRONINE (T-3) AND ESTRADIOL (E(2)) ON THYROID-HORMONE NUCLEAR RECEPTOR EXPRESSION IN HUMAN HEPATOCYTE PRIMARY CULTURES, Alcohol and alcoholism, 30(2), 1995, pp. 219-221

Authors: GITTOES NJL FRANKLYN JA
Citation: Njl. Gittoes et Ja. Franklyn, DRUG-INDUCED THYROID-DISORDERS, Drug safety, 13(1), 1995, pp. 46-55

Authors: EGGO MC HOPKINS JM FRANKLYN JA JOHNSON GD SANDERS DSA SHEPPARD MC
Citation: Mc. Eggo et al., EXPRESSION OF FIBROBLAST GROWTH-FACTORS IN THYROID-CANCER, The Journal of clinical endocrinology and metabolism, 80(3), 1995, pp. 1006-1011

Authors: WILLIAMS GR FRANKLYN JA
Citation: Gr. Williams et Ja. Franklyn, PHYSIOLOGY OF THE STEROID THYROID-HORMONE NUCLEAR RECEPTOR SUPERFAMILY, Bailliere's clinical endocrinology and metabolism, 8(2), 1994, pp. 241-266

Authors: FRANKLYN JA
Citation: Ja. Franklyn, THE MANAGEMENT OF HYPERTHYROIDISM (VOL 330, PG 1731, 1994), The New England journal of medicine, 331(8), 1994, pp. 559-559

Authors: FRANKLYN JA
Citation: Ja. Franklyn, DRUG-THERAPY - THE MANAGEMENT OF HYPERTHYROIDISM, The New England journal of medicine, 330(24), 1994, pp. 1731-1738

Authors: FRANKLYN JA BLACK EG BETTERIDGE J SHEPPARD MC
Citation: Ja. Franklyn et al., COMPARISON OF 2ND AND 3RD GENERATION METHODS FOR MEASUREMENT OF SERUMTHYROTROPIN IN PATIENTS WITH OVERT HYPERTHYROIDISM, PATIENTS RECEIVING THYROXINE THERAPY, AND THOSE WITH NONTHYROIDAL ILLNESS, The Journal of clinical endocrinology and metabolism, 78(6), 1994, pp. 1368-1371

Authors: FRANKLYN JA SHEPPARD MC
Citation: Ja. Franklyn et Mc. Sheppard, AMIODARONE AND THYROID-DYSFUNCTION, Trends in endocrinology and metabolism, 4(4), 1993, pp. 128-131

Authors: FRANKLYN JA DAYKIN J YOUNG J OATES GD SHEPPARD MC
Citation: Ja. Franklyn et al., FINE-NEEDLE ASPIRATION CYTOLOGY IN DIFFUSE OR MULTINODULAR GOITER COMPARED WITH SOLITARY THYROID-NODULES, BMJ. British medical journal, 307(6898), 1993, pp. 240-240

Authors: FRANKLYN JA DAYKIN J BETTERIDGE J HUGHES EA HOLDER R JONES SR SHEPPARD MC
Citation: Ja. Franklyn et al., THYROXINE REPLACEMENT THERAPY AND CIRCULATING LIPID CONCENTRATIONS, Clinical endocrinology, 38(5), 1993, pp. 453-459

Authors: FRANKLYN JA
Citation: Ja. Franklyn, GRAVES OPHTHALMOPATHY AND THE TSH RECEPTOR, Lancet, 342(8867), 1993, pp. 318-319

Authors: BAXTER MA STEWART PM DAYKIN J SHEPPARD MC FRANKLYN JA
Citation: Ma. Baxter et al., RADIOIODINE THERAPY FOR HYPERTHYROIDISM IN YOUNG-PATIENTS - PERCEPTION OF RISK AND USE, Quarterly Journal of Medicine, 86(8), 1993, pp. 495-499

Authors: YARWOOD NJ GURR JA SHEPPARD MC FRANKLYN JA
Citation: Nj. Yarwood et al., ESTRADIOL MODULATES THYROID-HORMONE REGULATION OF THE HUMAN GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE, The Journal of biological chemistry, 268(29), 1993, pp. 21984-21989
Risultati: 1-25 | 26-42 |